Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 60 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-08-28 EMSTER KURT VON Director Sale −88,011 $19.79 $1.7M 1,951,359
2017-08-28 Novak Rodger Chief Executive Officer Option exercise +17,692 $1.81 $32K 1,232,697
2017-08-28 Novak Rodger Chief Executive Officer Sale −17,692 $20.06 $355K 1,215,005
2017-08-28 Novak Rodger Chief Executive Officer Option exercise · Stock Options (Right to Buy) −17,692 50,401
2017-08-28 Kulkarni Samarth Chief Business Officer Sale −23,154 $20.09 $465K 110,893
2017-08-25 EMSTER KURT VON Director Sale −14,913 $19.52 $291K 2,039,370
2017-08-24 EMSTER KURT VON Director Sale −7,868 $19.23 $151K 2,054,283
2017-08-23 EMSTER KURT VON Director Sale −7,035 $18.53 $130K 2,062,151
2017-08-22 EMSTER KURT VON Director Sale −10,954 $18.53 $203K 2,069,186
2017-08-21 EMSTER KURT VON Director Sale −1,250 $18.51 $23K 2,080,140
2017-08-18 EMSTER KURT VON Director Sale −1,900 $18.53 $35K 2,081,390
2017-08-17 EMSTER KURT VON Director Sale −13,593 $18.74 $255K 2,083,290
2017-08-16 EMSTER KURT VON Director Sale −20,548 $19.27 $396K 2,096,883
2017-08-15 EMSTER KURT VON Director Sale −25,586 $19.53 $500K 2,117,431
2017-08-14 EMSTER KURT VON Director Sale −29,983 $19.64 $589K 2,143,017
2016-10-24 GLAXOSMITHKLINE PLC 10% owner Conversion +2,942,560 2,942,560
2016-10-24 GLAXOSMITHKLINE PLC 10% owner Conversion +211,567 3,154,127
2016-10-24 GLAXOSMITHKLINE PLC 10% owner Purchase +66,500 $14.00 $931K 3,220,627
2016-10-24 GLAXOSMITHKLINE PLC 10% owner Conversion · Series A-3 Preferred Shares −2,942,560 0
2016-10-24 GLAXOSMITHKLINE PLC 10% owner Conversion · Series B Preferred Shares −211,567 0

Page 61 of 62 · 1,221 trades